Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Developmental Cell|September 17, 2021
Endosomal trafficking and DNA damage checkpoint kinases dictate survival to replication stress by regulating amino acid uptake and protein synthesisArta Ajazi, Christopher Bruhn, Ghadeer Shubassi, et al.
Human Molecular Genetics|January 8, 2011
Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal modelSara Ricciardi, Elena M Boggio, Stefano Grosso, et al.
Microbiology Spectrum|June 26, 2023
FAM46C Is an Interferon-Stimulated Gene That Inhibits Lentiviral Particle Production by Modulating AutophagyMarilena Mancino, Giancarlo Lai, Federica De Grossi, et al.
Data in Brief|September 20, 2017
Data on the effects of eIF6 downmodulation on the proportions of innate and adaptive immune system cell subpopulations and on thymocyte maturationNicola Manfrini, Sara Ricciardi, Annarita Miluzio, et al.
Molecular and Cellular Biology|September 12, 2018
RACK1 Specifically Regulates Translation through Its Binding to RibosomesSimone Gallo, Sara Ricciardi, Nicola Manfrini, et al.
Nucleic Acids Research|May 1, 2015
The ribonuclease DIS3 promotes let-7 miRNA maturation by degrading the pluripotency factor LIN28B mRNASimona Segalla, Silvia Pivetti, Katia Todoerti, et al.
Nature Communications|August 13, 2021
Targeting of eIF6-driven translation induces a metabolic rewiring that reduces NAFLD and the consequent evolution to hepatocellular carcinomaAlessandra Scagliola, Annarita Miluzio, Gabriele Ventura, et al.
Developmental and Comparative Immunology|July 27, 2017
High levels of eukaryotic Initiation Factor 6 (eIF6) are required for immune system homeostasis and for steering the glycolytic flux of TCR-stimulated CD4+ T cells in both mice and humansNicola Manfrini, Sara Ricciardi, Annarita Miluzio, et al.
Science (New York, N.Y.)|July 28, 2007
MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4FGéraldine Mathonnet, Marc R Fabian, Yuri V Svitkin, et al.
Frontiers in Bioengineering and Biotechnology|October 17, 2024
A millifluidic bioreactor allows the long term culture of primary lymphocytes or CD34+ hematopoietic cells while allowing the detection of tumorigenic expansionPaolo Ritter, Stefania Oliveto, Chiara Cordiglieri, et al.
Pageof 9